THE HEALTH AND ECONOMIC CONSEQUENCES OF DELAY IN STARTING DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Van Doornum, S. [1 ,2 ]
Franklyn, K. [2 ]
Tacey, M. [1 ,2 ]
Roberts, C. [1 ,2 ]
Liew, D. [1 ,2 ]
机构：
[1] Univ Melbourne, Melbourne, Vic 3010, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2013年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [1] THE HEALTH AND ECONOMIC CONSEQUENCES OF DELAY IN STARTING DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN RHEUMATOID ARTHRITIS
    Van Doornum, S.
    Roberts, L.
    Reed, M. D.
    Liew, D.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A448 - A448
  • [2] Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?
    Cannella, AC
    O'Dell, JR
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (03) : 185 - 192
  • [3] Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
    Solomon, Daniel H.
    Tonner, Chris
    Lu, Bing
    Kim, Seoyoung C.
    Ayanian, John Z.
    Brookhart, M. Alan
    Katz, Jeffrey N.
    Yelin, Ed
    [J]. ARTHRITIS CARE & RESEARCH, 2014, 66 (08) : 1152 - 1158
  • [4] The Health and Economic Consequences Of Delay In Starting Disease-Modifying Anti-Rheumatic Drugs In Australian Patients With Early Rheumatoid Arthritis
    Liew, Danny
    Tacey, Mark
    Van Doornum, Sharon
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S75 - S75
  • [5] Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis
    Grijalva, Carlos G.
    Chung, Cecilia P.
    Arbogast, Patrick G.
    Stein, Charles M.
    Mitchel, Edward F., Jr.
    Griffin, Marie R.
    [J]. MEDICAL CARE, 2007, 45 (10) : S66 - S76
  • [6] Priorities for improvement in health in patients with rheumatoid arthritis (RA) who are starting disease-modifying antirheumatic drugs (DMARDs), including biological agents
    Heiberg, T
    Vinders, M
    Olsen, CL
    Magnussen, AS
    Enersen, TB
    Fekete, S
    Kvien, TK
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 558 - 558
  • [7] Survival of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Rosales Rosado, Zulema
    Leon, Leticia
    Freites Nunez, Dalifer
    Font Urgelles, Judit
    Leon Cardenas, Cynthia Milagros
    Vadillo Font, Cristina
    Rodriguez Rodriguez, Luis
    Jover Jover, Juan A.
    Abasolo Alcazar, Lydia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
    Khoshroo, Ahmadreza
    Ramezani, Keyvan
    Moghimi, Niusha
    Bonakdar, Moein
    Ramezani, Nazanin
    [J]. INFLAMMOPHARMACOLOGY, 2023, 31 (02) : 689 - 697
  • [9] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
    Ahmadreza Khoshroo
    Keyvan Ramezani
    Niusha Moghimi
    Moein Bonakdar
    Nazanin Ramezani
    [J]. Inflammopharmacology, 2023, 31 : 689 - 697
  • [10] INDICATIONS FOR STARTING OR CHANGING DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS PATIENTS
    YANNI, G
    CHOY, EHS
    KINGSLEY, GH
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1993, 11 (06) : 693 - 693
12345